Advertisement

Pharmaceutical Research

, Volume 24, Issue 12, pp 2207–2212 | Cite as

Nail Swelling as a Pre-formulation Screen for the Selection and Optimisation of Ungual Penetration Enhancers

  • R. H. Khengar
  • S. A. JonesEmail author
  • R. B. Turner
  • B. Forbes
  • M. B. Brown
Research Paper

Abstract

Introduction

Targeting drug treatment to fungal infections that reside within or below the nail plate is problematic due to the highly restrictive barrier of the human nail. To optimise topical formulations for ungual drug delivery, inclusion of an effective penetration enhancer (PE) is imperative. At present, in vitro nail permeation studies can take weeks or months in order to obtain any meaningful data because the lack of a simple in vitro model to identify and develop nail PEs makes the selection and optimisation of novel PEs an empirical and inefficient process. The aim of this study was to compare three methods for pre-formulation screening of putative ungual PEs and then to select the most suitable technique for screening candidates that may enhance the permeation of therapeutic agents through the human nail.

Methods

Three screening techniques were evaluated; nail swelling (weight increase of human nail clippings), horse hoof swelling (weight increase of horse hoof clippings) and nail penetration of a radiolabelled permeability probe. Four test PEs were evaluated using each screening method and nail swelling was identified as a simple, rapid, economic, relevant and reliable technique. This screen was then used to evaluate 20 potential PEs. Thioglycolic acid (TA), hydrogen peroxide (H2O2) and urea H2O2 produced the greatest nail weight increases; 71.0 ± 4.6%, 69.2 ± 6.6%, and 69.0 ± 9.9 respectively. To confirm the relationship between human nail swelling and altered ungual barrier function, a permeation study was performed in human nails using caffeine as a model penetrant.

Results and Discussion

Human nails pre-treated with TA in vitro had a 3.8-fold increase in caffeine flux compared to the control (TA-free solution). This study illustrated the potential to use human nail clipping swelling as a surrogate marker of PE activity for topical ungual drug delivery.

Key words

nail onychomycosis penetration enhancers ungual water uptake 

Notes

Acknowledgements

Thank you to MedPharm Ltd for financial support.

References

  1. 1.
    B. E. Elewski. Onychomycosis: Pathogenesis, diagnosis, and management. Clin. Microbiol. Rev. 11:415–429 (1998).PubMedGoogle Scholar
  2. 2.
    S. Murdan. Drug delivery to the nail following topical application. Int. J. Pharm. 236:1–26 (2002).PubMedCrossRefGoogle Scholar
  3. 3.
    L. A. Drake, R. K. Scher, E. B. Smith, G. A. Faich, S. L. Smith, J. J. Hong, and M. J. Stiller. Effect of onychomycosis on quality of life. J. Am. Acad. Dermatol. 38:702–704 (1998).PubMedCrossRefGoogle Scholar
  4. 4.
    R. K. Scher. Onychomycosis: A significant medical disorder. J. Am. Acad. Dermatol. 35:S2–S5 (1996).PubMedCrossRefGoogle Scholar
  5. 5.
    C. Ajit, A. Suvannasankha, N. Zaeri, and S. J. Munoz. Terbinafine-associated hepatotoxicity. Am. J. Med. Sci. 325:292–295 (2003).PubMedCrossRefGoogle Scholar
  6. 6.
    W. M. Chambers, A. Millar, S. Jain, and A. K. Burroughs. Terbinafine-induced hepatic dysfunction. Eur. J. Gastroenterol. Hepatol. 13:1115–1118 (2001).PubMedCrossRefGoogle Scholar
  7. 7.
    Y. Kobayashi, M. Miyamoto, K. Sugibayashi, and Y. Morimoto. Drug permeation through the three layers of the human nail plate. J. Pharm. Pharmacol. 51:271–278 (1999).PubMedCrossRefGoogle Scholar
  8. 8.
    D. Mertin and B. C. Lippold. In vitro permeability of the human nail and of a keratin membrane from bovine hooves: Prediction of the penetration rate of antimycotics through the nail plate and their efficiency. J. Pharm. Pharmacol. 49:866–872 (1997).PubMedGoogle Scholar
  9. 9.
    K. A. Walters, G. L. Flynn, and J. R. Marvel. Physicochemical characterization of the human nail—permeation pattern for water and the homologous alcohols and differences with respect to the stratum-corneum. J. Pharm. Pharmacol. 35:28–33 (1983).PubMedGoogle Scholar
  10. 10.
    R. P. R. Dawber. The ultrastructure and growth of human nails. Arch. Dermatol. Res. 269:197–204 (1980).PubMedCrossRefGoogle Scholar
  11. 11.
    J. C. Garson, F. Baltenneck, F. Leroy, C. Riekel, and M. Muller. Histological structure of human nail as studied by synchrotron X-ray microdiffraction. Cell. Mol. Biol. 46:1025–1034 (2000).PubMedGoogle Scholar
  12. 12.
    G. B. E. Jemec, T. Agner, and J. Serup. Transonychial water-loss—relation to sex, age and nail-plate thickness. Br. J. Dermatol. 121:443–446 (1989).PubMedCrossRefGoogle Scholar
  13. 13.
    K. A. Walters, G. L. Flynn, and J. R. Marvel. Physicochemical characterization of the human nail—solvent effects on the permeation of homologous alcohols. J. Pharm. Pharmacol. 37:771–775 (1985).PubMedGoogle Scholar
  14. 14.
    J. H. Kim, C. H. Lee, and H. K. Choi. A method to measure the amount of drug penetrated across the nail plate. Pharm. Res. 18:1468–1471 (2001).PubMedCrossRefGoogle Scholar
  15. 15.
    D. Monti, L. Saccomani, P. Chetoni, S. Burgalassi, M. F. Saettone, and F. Mailland. In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer. Drug Dev. Ind. Pharm. 31:11–17 (2005).PubMedGoogle Scholar
  16. 16.
    Y. Myoung and H. K. Choi. Permeation of ciclopirox across porcine hoof membrane: effect of pressure sensitive adhesives and vehicles. Eur. J. Pharm. Sci. 20:319–325 (2003).PubMedCrossRefGoogle Scholar
  17. 17.
    H. P. Baden, L. A. Goldsmit, and B. Fleming. Comparative study of physicochemical properties of human keratinized tissues. Biochim. Biophys. Acta 322:269–278 (1973).PubMedGoogle Scholar
  18. 18.
    R. C. Marshall and J. M. Gillespie. Keratin proteins of wool, horn and hoof from sheep. Aust. J. Biol. Sci. 30:389–400 (1977).Google Scholar
  19. 19.
    Johnson and Johnson patent. Method for increasing the permeability of horny human tissue. International Publication Number WO 99/4985 (1999).Google Scholar
  20. 20.
    I. Ghersetich, P. Teofoll, M. Gantcheva, M. Ribuffo, and P. Puddu. Chemical peeling: How, when, why?. J. Eur. Acad. Dermatol. Venereol. 8:1–11 (1997).CrossRefGoogle Scholar
  21. 21.
    J. Alkiewicz, and R. Pfister. Atlas der Nagelkrankheiten. Schattauer–Verlag, Stuttgart, 1976, p. 8.Google Scholar
  22. 22.
    Y. Sun, J. C. Liu, J. C. T. Wang, and P. De Doncker. Nail penetration. Focus on topical delivery of antifungal drugs for onychomycosis treatment. In R. L. Bronaugh, and H. I. Maibach R. L. Bronaugh H. I. Maibach (eds.), Percutaneous Absorption. Drugs–Cosmetics–Mechanisms–Methodology, 3rd, Marcel Dekker Inc, New York, 1999, pp. 759–787.Google Scholar
  23. 23.
    F. Akomeah, T. Nazir, G. P. Martin, and M. B. Brown. Effect of heat on the percutaneous absorption and skin retention of three model penetrants. Eur. J. Pharm. Sci. 21:337–345 (2004).PubMedCrossRefGoogle Scholar
  24. 24.
    Y. Kobayashi, T. Komatsu, M. Sumi, S. Numajiri, M. Miyamoto, D. Kobayashi, K. Sugibayashi, and Y. Morimoto. In vitro permeation of several drugs through the human nail plate: relationship between physicochemical properties and nail permeability of drugs. Eur. J. Pharm. Sci. 21:471–477 (2004).PubMedCrossRefGoogle Scholar
  25. 25.
    C. R. Behl, G. L. Flynn, T. Kurihara, N. Harper, W. Smith, W. I. Higuchi, N. F. H. Ho, and C. L. Pierson. Hydration and percutaneous absorption 1. influence of hydration on alkanol permeation through hairless mouse skin. J. Invest. Dermatol. 75:346–352 (1980).PubMedCrossRefGoogle Scholar
  26. 26.
    E. A. Olsen. Methods of hair removal. J. Am. Acad. Dermatol. 40:143–155 (1999).PubMedCrossRefGoogle Scholar
  27. 27.
    S. Harrison and R. Sinclair. Hair colouring, permanent styling and hair structure. J. Cosmet. Dermatol. 2:180–185 (2004).CrossRefGoogle Scholar
  28. 28.
    N. Nishikawa, Y. Tanizawa, S. Tanaka, Y. Horiguchi, and T. Asakura. Structural change of keratin protein in human hair by permanent waving treatment. Polymers 39:3835–3840 (1998).CrossRefGoogle Scholar
  29. 29.
    C. Bolduc and J. Shapiro. Hair care products: waving, straightening, conditioning, and coloring. Clin. Dermatol. 19:431–436 (2001).PubMedCrossRefGoogle Scholar
  30. 30.
    A. M. D. R. Gonsalves, R. A. W. Johnstone, M. M. Pereira, and J. Shaw. Dissociation of hydrogen–peroxide adducts in solution—the use of such adducts for epoxidation of alkenes. J. Chem. Res S8:208–209 (1991).Google Scholar
  31. 31.
    M. Egawa, Y. Ozaki, and M. Takahashi. In vivo measurement of water content of the fingernail and its seasonal change. Skin Res. Technol. 12:126–132 (2006).PubMedCrossRefGoogle Scholar
  32. 32.
    X. Y. Hui, R. C. Wester, S. Barbadillo, C. Lee, B. Patel, M. Wortzmman, E. H. Gans, and H. I. Maibach. Ciclopirox delivery into the human nail plate. J. Pharm. Sci. 93:2545–2548 (2004).PubMedCrossRefGoogle Scholar
  33. 33.
    D. A. Godwin and B. B. Michniak. Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Devel. Ind. Pharm. 25:905–915 (1999).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • R. H. Khengar
    • 1
  • S. A. Jones
    • 1
    Email author
  • R. B. Turner
    • 2
  • B. Forbes
    • 1
  • M. B. Brown
    • 2
    • 3
  1. 1.Pharmaceutical Science Research DivisionKing’s College LondonLondonUK
  2. 2.MedPharm LtdGuildfordUK
  3. 3.School of PharmacyUniversity of HertfordshireHatfieldUK

Personalised recommendations